Industry Experts

Bart Hendriks is an Executive Director of Pharmacokinetic Sciences at Novartis in Cambridge, MA USA. He has over 20 years of experience in biopharma and currently works in oncology, where he and his team support DMPK and clinical pharmacology aspects of a wide variety of small molecule and biologic programs from early discovery through approval and life cycle management. Prior to Novartis, Bart has held positions of increasing responsibility at AstraZeneca, Pfizer, Merrimack Pharmaceuticals, and EMD Serono. He holds a Ph.D. from MIT in Chemical Engineering.